The marketing authorisation for ProMeris has been withdrawn at the request of the marketing authorisation holder.
ProMeris : EPAR - Summary for the public (PDF/191.74 KB)
First published: 10/01/2007
Last updated: 14/07/2015
|Agency product number||
|International non-proprietary name (INN) or common name||
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
|Date of issue of marketing authorisation valid throughout the European Union||
Kent CT13 9NJ
08/07/2015 ProMeris - EMEA/V/C/000107 - IB/0012
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Ectoparasiticides for topical use, incl. insecticides
Treatment and prevention of flea infestations (Ctenocephalides canis and C. felis) in cats. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).